M3V Mevis Medical Solutions

DGAP-News: MeVis Medical Solutions AG: Marcus Kirchhoff becomes sole Executive Board Member

DGAP-News: MeVis Medical Solutions AG / Key word(s): Personnel
MeVis Medical Solutions AG: Marcus Kirchhoff becomes sole Executive Board Member

07.05.2019 / 18:41
The issuer is solely responsible for the content of this announcement.


Bremen, May 7, 2019 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, announces a change in its Executive Board.

As of April 1, 2019, Marcus Kirchhoff has taken over as sole member of the Executive Board of MeVis Medical Solutions AG. Kirchhoff was appointed to the Executive Board in 2012 as CEO and, in addition to his previous activities in this function, will now also be responsible for oversight of Finance, Human Resources and IT activities.

The former Chief Financial Officer Dr. Robert Hannemann left the company at his own request and reached an agreement with the Supervisory Board on the premature termination of his mandate. The Executive Board and Supervisory Board would like to thank Dr. Hannemann for his dedicated work over more than 8 years.

"Dr. Robert Hannemann has played a decisive role in co-managing the company constructively and with great commitment. Especially during and after the takeover by the current majority shareholder, Varex Imaging Corporation, Dr. Hannemann made a significant contribution with his expertise and competence. On behalf of the entire Supervisory Board, I would also like to thank him personally for his years of untiring commitment," emphasized Kim Honeysett, Chairperson of the Supervisory Board. "We wish Dr. Hannemann all the best for the future. The management of MeVis Medical Solutions AG will now be led by Marcus Kirchhoff, as sole Executive Board member, and his experienced capable management team. We know and appreciate Mr. Kirchhoff from the good cooperation so far and look forward to a continued successful future of the company under his leadership."

************************************************************************

Contact:
Kirchhoff, Marcus / CEO


07.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: 0
Fax: 999
E-mail:
Internet:
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 808285

 
End of News DGAP News Service

808285  07.05.2019 

fncls.ssp?fn=show_t_gif&application_id=808285&application_name=news&site_id=research_pool
EN
07/05/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mevis Medical Solutions

 PRESS RELEASE

EQS-News: MeVis publishes figures for the first half of fiscal year 20...

EQS-News: MeVis Medical Solutions AG / Key word(s): Half Year Results MeVis publishes figures for the first half of fiscal year 2023/2024 27.05.2024 / 12:00 CET/CEST The issuer is solely responsible for the content of this announcement. Bremen, May 27, 2024 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading medical imaging software company, today announced its results for the first half of fiscal year 2023/2024, reporting period October 1, 2023 to March 31, 2024. In the first half of the year, the company's revenue amounted to € 8,774 k (previous year: € 8,472 ...

 PRESS RELEASE

EQS-News: MeVis veröffentlicht Zahlen für das erste Halbjahr im Geschä...

EQS-News: MeVis Medical Solutions AG / Schlagwort(e): Halbjahresergebnis MeVis veröffentlicht Zahlen für das erste Halbjahr im Geschäftsjahr 2023/2024 27.05.2024 / 12:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Bremen, 27. Mai 2024 – Die MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], ein führendes Softwareunternehmen der medizinischen Bildgebung, gibt heute die Ergebnisse des ersten Halbjahres im Geschäftsjahr 2023/2024, Berichtszeitraum 1. Oktober 2023 bis 31. März 2024, bekannt. im ersten Halbjahr betrugen die Umsatzerlöse...

 PRESS RELEASE

EQS-News: MeVis veröffentlicht Zahlen für das Geschäftsjahr 2022/2023 ...

EQS-News: MeVis Medical Solutions AG / Schlagwort(e): Jahresergebnis MeVis veröffentlicht Zahlen für das Geschäftsjahr 2022/2023 und Prognose für 2023/2024 29.01.2024 / 19:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Umsatz um € 1,5 Mio. auf € 17,3 Mio. gesunken EBIT in Höhe von € 3,9 Mio., 23 % Marge Ergebnis nach Steuern um € 2,9 Mio auf € 4,9 Mio. gesunken Prognose für das Geschäftsjahr 2023/2024 Leicht steigender Umsatz von € 18,0 Mio. bis € 18,5 Mio. EBIT stabil mit € 4,5 Mio. bis € 5,0 Mio.   Bremen, 29. Januar 20...

 PRESS RELEASE

EQS-News: MeVis publishes figures for financial year 2022/2023 and for...

EQS-News: MeVis Medical Solutions AG / Key word(s): Annual Results MeVis publishes figures for financial year 2022/2023 and forecast for 2023/2024 29.01.2024 / 19:00 CET/CEST The issuer is solely responsible for the content of this announcement. Turnover down by € 1.5 million to € 17.3 million EBIT of € 3.9 million, 23% margin Earnings after taxes down by € 2.9 million to € 4.9 million Forecast for the 2023/2024 financial year Slight increase in sales from € 18.0 million to € 18.5 million EBIT stable at € 4.5 million to € 5.0 million   Bremen, January 29, 2024 - ...

 PRESS RELEASE

EQS-News: MeVis Medical Solutions AG: MeVis veröffentlicht Zahlen für...

EQS-News: MeVis Medical Solutions AG / Schlagwort(e): Halbjahresbericht MeVis Medical Solutions AG: MeVis veröffentlicht Zahlen für das erste Halbjahr im Geschäftsjahr 2022/2023 25.05.2023 / 15:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Bremen, 25. Mai 2023 – Die MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], ein führendes Softwareunternehmen der medizinischen Bildgebung, gibt heute die Ergebnisse des ersten Halbjahres im Geschäftsjahr 2022/2023, Berichtszeitraum 1. Oktober 2022 bis 31. März 2023, bekannt. Im ersten Halbja...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch